As of 2013, two further clinical studies were reported to be underway in rheumatoid arthritis patients to investigate these effects further.<ref>{{cite journal|url=|title=Mavrilimumab: an evidence based review of its potential in the treatment of rheumatoid arthritis|author1=Manuela Di Franco |author2=Maria Chiara Gerardi |author3=Bruno Lucchino |author4=Fabrizio Conti  |last-author-amp=yes |journal=Core Evidence|volume=9|pages=41â€“48|date=12 March 2014|doi=10.2147/CE.S39770|PMC=3958547 |pmid=24648832}}</ref>
